Dr. Halfdanarson on Molecular Differences Between Left- Versus Right-Sided Tumors in CRC


In Partnership With:

Thorvardur (Thor) Halfdanarson, MD, discusses the molecular differences between left- versus right-sided tumors in colorectal cancer.

Thorvardur (Thor) Halfdanarson, MD, an associate professor of medicine, Division of Medical Oncology; a medical oncologist; and an assistant program director for the Hematology/Oncology fellowship program at Mayo Clinic, discusses the molecular differences between left- versus right-sided tumors in colorectal cancer (CRC).

In terms of tumor sidedness, it has been known for a long time that right-sided tumors are more likely to be BRAF mutated, says Halfdanarson. Patients with BRAF-mutant tumors have a very poor prognosis compared with those who have BRAF wild-type tumors. More recently, it has also been confirmed that not all BRAF-mutanttumors are created equal. Different mutations exist within CRC, one of the most common being BRAF V600E, notes Halfdanarson. Other BRAF mutations, however, may be associated with prognosis in a different way; not all of them are associated with an inferior prognosis.

With the mismatch repair–deficient (dMMR) tumors, there is an interesting paradox, notes Halfdanarson. In general, right-sided tumors have a worse prognosis; this has been demonstrated in several trials. BRAF-mutant, right-sided tumors are also more likely to be dMMR, although that represents a relatively small proportion of all right-sided tumors. That small subgroup of patients with right-sided tumors responds well to immunotherapy, concludes Halfdanarson.

Related Videos
Jorge J. Castillo, MD,
Heinz-Josef Lenz, MD, FACP
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Omid Hamid, MD, professor, medicine, Cedars-Sinai; director, Clinical Research and Immunotherapy, director, Cutaneous Oncology and Melanoma, The Angeles Clinic and Research Institute
Christina L. Roland, MD, MS, FACS
Ashish Saxena, MD, PhD
Shruti Tiwari, MD
Scott Kopetz, MD, PhD, FACP
Katharina Hoebel, MD, PhD
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine